| 4841 |
7S7I |
IM_B |
7S7I Fab |
Human MHC class I chain-related protein A |
Homo sapiens |
XRD |
2.4 | 10.1021/acs.analchem.2c03091 |
| 4842 |
7S7I |
JN_C |
7S7I Fab |
Human MHC class I chain-related protein A |
Homo sapiens |
XRD |
2.4 | 10.1021/acs.analchem.2c03091 |
| 4843 |
7S7I |
UV_D |
7S7I Fab |
Human MHC class I chain-related protein A |
Homo sapiens |
XRD |
2.4 | 10.1021/acs.analchem.2c03091 |
| 4844 |
7S7I |
WX_E |
7S7I Fab |
Human MHC class I chain-related protein A |
Homo sapiens |
XRD |
2.4 | 10.1021/acs.analchem.2c03091 |
| 4845 |
7S7I |
YZ_F |
7S7I Fab |
Human MHC class I chain-related protein A |
Homo sapiens |
XRD |
2.4 | 10.1021/acs.analchem.2c03091 |
| 4846 |
7S7R |
B_A |
G7 Nanobody |
Plasmodium falciparum merozoite surface protein P12 |
Plasmodium falciparum 3D7, Vicugna pacos |
XRD |
1.77 | 10.1093/femsmc/xtac005 |
| 4847 |
7S83 |
A_C |
ShAb01 variable new antigen receptor (VNAR) VHH |
SARS-CoV-2 spike glycoprotein RBD |
Ginglymostoma cirratum, Severe acute respiratory syndrome coronavirus 2 |
XRD |
2.52 | 10.1038/s41467-023-36106-x |
| 4848 |
7S83 |
B_C |
ShAb02 variable new antigen receptor (VNAR) VHH |
SARS-CoV-2 spike glycoprotein RBD |
Ginglymostoma cirratum, Severe acute respiratory syndrome coronavirus 2 |
XRD |
2.52 | 10.1038/s41467-023-36106-x |
| 4849 |
7SBD |
HL_C |
7SBD Fab |
Profilin-2 |
Mus musculus, Hevea brasiliensis |
XRD |
3.04 | 10.1038/s42003-022-03718-w |
| 4850 |
7SBG |
HL_C |
7SBG Fab |
Profilin-2 |
Mus musculus, Hevea brasiliensis |
XRD |
3.34 | 10.1038/s42003-022-03718-w |
| 4851 |
7SBU |
HL_A |
J08 Fab |
SARS-CoV-2 spike glycoprotein RBD |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
XRD |
2.53 | 10.1073/pnas.2120976119 |
| 4852 |
7SC1 |
HL_A |
R40-1G8 Fab |
SARS-CoV-2 S 6P spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
EM |
3.2 | 10.1016/j.chom.2021.12.010 |
| 4853 |
7SC1 |
MN_B |
R40-1G8 Fab |
SARS-CoV-2 S 6P spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
EM |
3.2 | 10.1016/j.chom.2021.12.010 |
| 4854 |
7SC1 |
PQ_C |
R40-1G8 Fab |
SARS-CoV-2 S 6P spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
EM |
3.2 | 10.1016/j.chom.2021.12.010 |
| 4855 |
7SCN |
HL_B |
310-63E6 Fab |
Influenza A virus South Canterbury/35/2000 H1N1 NC99 hemagglutinin |
Influenza A virus (A/South Canterbury/35/2000(H1N1)), Homo sapiens |
EM |
3.02 | 10.1016/j.immuni.2022.07.006 |
| 4856 |
7SCN |
EF_D |
310-63E6 Fab |
Influenza A virus South Canterbury/35/2000 H1N1 NC99 hemagglutinin |
Influenza A virus (A/South Canterbury/35/2000(H1N1)), Homo sapiens |
EM |
3.02 | 10.1016/j.immuni.2022.07.006 |
| 4857 |
7SCN |
JK_I |
310-63E6 Fab |
Influenza A virus South Canterbury/35/2000 H1N1 NC99 hemagglutinin |
Influenza A virus (A/South Canterbury/35/2000(H1N1)), Homo sapiens |
EM |
3.02 | 10.1016/j.immuni.2022.07.006 |
| 4858 |
7SCN |
HL_A |
310-63E6 Fab |
Influenza A virus South Canterbury/35/2000 H1N1 NC99 hemagglutinin |
Influenza A virus (A/South Canterbury/35/2000(H1N1)), Homo sapiens |
EM |
3.02 | 10.1016/j.immuni.2022.07.006 |
| 4859 |
7SCN |
EF_C |
310-63E6 Fab |
Influenza A virus South Canterbury/35/2000 H1N1 NC99 hemagglutinin |
Influenza A virus (A/South Canterbury/35/2000(H1N1)), Homo sapiens |
EM |
3.02 | 10.1016/j.immuni.2022.07.006 |
| 4860 |
7SCN |
JK_G |
310-63E6 Fab |
Influenza A virus South Canterbury/35/2000 H1N1 NC99 hemagglutinin |
Influenza A virus (A/South Canterbury/35/2000(H1N1)), Homo sapiens |
EM |
3.02 | 10.1016/j.immuni.2022.07.006 |